PKI (14-24)amide TFA is an amidated inhibitory peptide segment used to evaluate kinase-regulation motifs. Its sequence supports conformational alignment with catalytic regions. Hydrophobic residues enhance binding studies. Researchers use it in mechanistic exploration of kinase-inhibitory domains.
CAT No: A40017
CAS No:1293946-39-0
Synonyms/Alias:PKI (14-24)amide TFA;1293946-39-0;PKI (14-24)amide (TFA);HY-P3929A;DA-66767;CS-0652891;
1. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
4. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
5. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.